FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 344:1651-1658 May 31, 2001 Number 22 Next

	Full Text PDF Editorial by Braunwald, E. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Beta-blocking agents reduce the risk of hospitalization and death in patients with mild-to-moderate heart failure, but little is known about their effects in severe heart failure.

Methods We evaluated 2289 patients who had symptoms of heart failure at rest or on minimal exertion, who were clinically euvolemic, and who had an ejection fraction of less than 25 percent. In a double-blind fashion, we randomly assigned 1133 patients to placebo and 1156 patients to treatment with carvedilol for a mean period of 10.4 months, during which standard therapy for heart failure was continued. Patients who required intensive care, had marked fluid retention, or were receiving intravenous vasodilators or positive inotropic drugs were excluded.

Results There were 190 deaths in the placebo group and 130 deaths in the carvedilol group. This difference reflected a 35 percent decrease in the risk of death with carvedilol (95 percent confidence interval, 19 to 48 percent; P=0.0014, adjusted for interim analyses). A total of 507 patients died or were hospitalized in the placebo group, as compared with 425 in the carvedilol group. This difference reflected a 24 percent decrease in the combined risk of death or hospitalization with carvedilol. The favorable effects on both end points were seen consistently in all the subgroups we examined. Fewer patients in the carvedilol group than in the placebo group withdrew because of adverse effects or for other reasons (P=0.02).

Conclusions The previously reported benefits of carvedilol with regard to morbidity and mortality in patients with mild-to-moderate heart failure were also found in the patients with severe heart failure who were evaluated in this trial.

Source Information

From the College of Physicians and Surgeons, Columbia University, New York (M.P.); Royal Brompton Hospital, London (A.J.S.C.); Stanford University Medical Center, Stanford, Calif. (M.B.F.); Universitäts Klinikum Lübeck, Lübeck, Germany (H.A.K.); Monash University, Prahran, Victoria, Australia (H.K.); University Hospital, Bern, Switzerland (P.M.); University Health Network and Mount Sinai Hospital, Toronto (J.L.R.); Silesian School of Medicine, Katowice, Poland (M.T.); Hôpital Henri Mondor, Paris (A.C.); and the University of Wisconsin, Madison (E.B.R., M.K.S., D.L.D.).

Other authors were Christoph Staiger, M.D., of Roche Pharmaceuticals, Basel, Switzerland; and Ellen L. Curtin, M.D., of GlaxoSmithKline, Philadelphia.

Address reprint requests to Dr. Packer at the Division of Circulatory Physiology, Columbia University College of Physicians and Surgeons, 630 W. 168th St., New York, NY 10032, or at mp65{at}columbia.edu.

Full Text of this Article

This article has been cited by other articles:

• Telli, M. L., Witteles, R. M., Fisher, G. A., Srinivas, S. (2008). Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate. Ann Oncol 19: 1613-1618 [Abstract] [Full Text]  
• Tardif, J.-C. (2008). The pivotal role of heart rate in clinical practice: from atherosclerosis to acute coronary syndrome. Eur Heart J Suppl 10: F11-F16 [Abstract] [Full Text]  
• Fonarow, G. C., Abraham, W. T., Albert, N. M., Stough, W. G., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., Sun, J. L., Yancy, C. W., Young, J. B., on behalf of the OPTIMIZE-HF Investigators and Coo, (2008). Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failure Findings From the OPTIMIZE-HF Program.. J Am Coll Cardiol 52: 190-199 [Abstract] [Full Text]  
• Mullens, W., Abrahams, Z., Francis, G. S., Skouri, H. N., Starling, R. C., Young, J. B., Taylor, D. O., Tang, W.H. W. (2008). Sodium nitroprusside for advanced low-output heart failure.. J Am Coll Cardiol 52: 200-207 [Abstract] [Full Text]  
• Couchonnal, L. F., Anderson, M. E. (2008). The Role of Calmodulin Kinase II in Myocardial Physiology and Disease. Physiology 23: 151-159 [Abstract] [Full Text]  
• Colucci, V. J, Berry, B. D (2008). Heart Failure Worsening and Exacerbation After Venlafaxine and Duloxetine Therapy. The Annals of Pharmacotherapy 42: 882-887 [Abstract] [Full Text]  
• MacDonald, M. R., Petrie, M. C., Hawkins, N. M., Petrie, J. R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., McMurray, J. J.V. (2008). Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J 29: 1224-1240 [Abstract] [Full Text]  
• Vittorio, T. J., Zolty, R., Kasper, M. E., Khandwalla, R. M., Hirsh, D. S., Tseng, C.-H., Jorde, U. P., Ahuja, K. (2008). Differential Effects of Carvedilol and Metoprolol Succinate on Plasma Norepinephrine Release and Peak Exercise Heart Rate in Subjects With Chronic Heart Failure. J CARDIOVASC PHARMACOL THER 13: 51-57 [Abstract]  
• Ramasubbu, K., Estep, J., White, D. L., Deswal, A., Mann, D. L. (2008). Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy.. J Am Coll Cardiol 51: 415-426 [Abstract] [Full Text]  
• Albert, N. M. (2007). Switching to Once-Daily Evidence-Based -Blockers in Patients With Systolic Heart Failure or Left Ventricular Dysfunction After Myocardial Infarction. Crit Care Nurse 27: 62-72 [Full Text]  
• Suma, H., Tanabe, H., Uejima, T., Suzuki, S., Horii, T., Isomura, T. (2007). Selected ventriculoplasty for idiopathic dilated cardiomyopathy with advanced congestive heart failure: midterm results and risk analysis. Eur. J. Cardiothorac. Surg. 32: 912-916 [Abstract] [Full Text]  
• Jourdain, P., Jondeau, G., Juilliere, Y. (2007). Reply. J Am Coll Cardiol 50: 2098-2099 [Full Text]  
• Esmore, D., Spratt, P., Larbalestier, R., Tsui, S., Fiane, A., Ruygrok, P., Meyers, D., Woodard, J. (2007). VentrAssistTM left ventricular assist device: clinical trial results and Clinical Development Plan update. Eur. J. Cardiothorac. Surg. 32: 735-744 [Abstract] [Full Text]  
• Hauptman, P. J., Goodlin, S. J., Lopatin, M., Costanzo, M. R., Fonarow, G. C., Yancy, C. W., for the ADHERE Scientific Advisory Committee and A, (2007). Characteristics of Patients Hospitalized With Acute Decompensated Heart Failure Who Are Referred for Hospice Care. Arch Intern Med 167: 1990-1997 [Abstract] [Full Text]  
• Granger, C. B (2007). Carvedilol was more effective than metoprolol for preventing cardiovascular events in heart failure. Evid. Based Med. 12: 141-141 [Full Text]  
• Kitsios, G., Zintzaras, E. (2007). Genetic Variation associated with Ischemic Heart Failure: A HuGE Review and Meta-Analysis. Am J Epidemiol 166: 619-633 [Abstract] [Full Text]  
• Swedberg, K. (2007). Pure heart rate reduction: further perspectives in heart failure. Eur Heart J Suppl 9: F20-F24 [Abstract] [Full Text]  
• Telli, M. L., Hunt, S. A., Carlson, R. W., Guardino, A. E. (2007). Trastuzumab-Related Cardiotoxicity: Calling Into Question the Concept of Reversibility. JCO 25: 3525-3533 [Abstract] [Full Text]  
• Bruch, C., Bruch, C., Sindermann, J., Breithardt, G., Gradaus, R. (2007). Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator. Europace 9: 681-686 [Abstract] [Full Text]  
• Torp-Pedersen, C., Metra, M., Charlesworth, A., Spark, P., Lukas, M. A., Poole-Wilson, P. A, Swedberg, K., Cleland, J. G F, Di Lenarda, A., Remme, W. J, Scherhag, A., for the COMET investigators, (2007). Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET). Heart 93: 968-973 [Abstract] [Full Text]  
• Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L. Jr, Kaplan, N. M., O'Connor, C. M., O'Gara, P. T., Oparil, S. (2007). REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Hypertension 50: e28-e55 [Full Text]  
• Fonarow, G. C., Abraham, W. T., Albert, N. M., Gattis Stough, W., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., Pieper, K., Sun, J. L., Yancy, C. W., Young, J. B., for the OPTIMIZE-HF Investigators and Hospitals, (2007). Influence of a Performance-Improvement Initiative on Quality of Care for Patients Hospitalized With Heart Failure: Results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch Intern Med 167: 1493-1502 [Abstract] [Full Text]  
• Fruhwald, F. M., Fahrleitner-Pammer, A., Berger, R., Leyva, F., Freemantle, N., Erdmann, E., Gras, D., Kappenberger, L., Tavazzi, L., Daubert, J.-C., Cleland, J. G.F. (2007). Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. Eur Heart J 28: 1592-1597 [Abstract] [Full Text]  
• Neglia, D., De Maria, R., Masi, S., Gallopin, M., Pisani, P., Pardini, S., Gavazzi, A., L'Abbate, A., Parodi, O. (2007). Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy. Heart 93: 808-813 [Abstract] [Full Text]  
• Watson, A. M. D., Hood, S. G., Ramchandra, R., McAllen, R. M., May, C. N. (2007). Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex. Am. J. Physiol. Heart Circ. Physiol. 293: H798-H804 [Abstract] [Full Text]  
• Pitt, B., Pitt, G. S. (2007). Added Benefit of Mineralocorticoid Receptor Blockade in the Primary Prevention of Sudden Cardiac Death. Circulation 115: 2976-2982 [Full Text]  
• Patel, J., Heywood, J. T. (2007). Mode of Death in Patients With Systolic Heart Failure. J CARDIOVASC PHARMACOL THER 12: 127-136 [Abstract]  
• Authors/Task Force Members, , Ryden, L., Standl, E., Bartnik, M., Berghe, G. V. d., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., Malmberg, K., Priori, S., Ostergren, J., Tuomilehto, J., Thrainsdottir, I., Other Contributors, , Vanhorebeek, I., Stramba-Badiale, M., Lindgren, P., Qiao, Q., ESC Committee for Practice Guidelines (CPG), , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, J., Dean, V., Deckers, J., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J., Zamorano, J. L., Document Reviewers, , Deckers, J. W., Bertrand, M., Charbonnel, B., Erdmann, E., Ferrannini, E., Flyvbjerg, A., Gohlke, H., Juanatey, J. R. G., Graham, I., Monteiro, P. F., Parhofer, K., Pyorala, K., Raz, I., Schernthaner, G., Volpe, M., Wood, D. (2007). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J Suppl 9: C3-C74 [Full Text]  
• Imai, M., Rastogi, S., Gupta, R. C., Mishra, S., Sharov, V. G., Stanley, W. C., Mika, Y., Rousso, B., Burkhoff, D., Ben-Haim, S., Sabbah, H. N. (2007). Therapy With Cardiac Contractility Modulation Electrical Signals Improves Left Ventricular Function and Remodeling in Dogs With Chronic Heart Failure. J Am Coll Cardiol 49: 2120-2128 [Abstract] [Full Text]  
• Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L. Jr, Kaplan, N. M., O'Connor, C. M., O'Gara, P. T., Oparil, S. (2007). Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 115: 2761-2788 [Full Text]  
• Ong, H T (2007). beta blockers in hypertension and cardiovascular disease. BMJ 334: 946-949 [Full Text]  
• Jourdain, P., Jondeau, G., Funck, F., Gueffet, P., Le Helloco, A., Donal, E., Aupetit, J. F., Aumont, M. C., Galinier, M., Eicher, J. C., Cohen-Solal, A., Juilliere, Y. (2007). Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure: The STARS-BNP Multicenter Study. J Am Coll Cardiol 49: 1733-1739 [Abstract] [Full Text]  
• Kasama, S., Toyama, T., Hatori, T., Sumino, H., Kumakura, H., Takayama, Y., Ichikawa, S., Suzuki, T., Kurabayashi, M. (2007). Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol. Eur Heart J 0: ehm048v1-7 [Abstract] [Full Text]  
• Taylor, A. L., Ziesche, S., Yancy, C. W., Carson, P., Ferdinand, K., Taylor, M., Adams, K., Olukotun, A. Y., Ofili, E., Tam, S. W., Sabolinski, M. L., Worcel, M., Cohn, J. N., on behalf of the African-American Heart Failure Tr, (2007). Early and Sustained Benefit on Event-Free Survival and Heart Failure Hospitalization From Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine: Consistency Across Subgroups in the African-American Heart Failure Trial. Circulation 115: 1747-1753 [Abstract] [Full Text]  
• Remme, W. J., Torp-Pedersen, C., Cleland, J. G.F., Poole-Wilson, P. A., Metra, M., Komajda, M., Swedberg, K., Di Lenarda, A., Spark, P., Scherhag, A., Moullet, C., Lukas, M. A. (2007). Carvedilol Protects Better Against Vascular Events Than Metoprolol in Heart Failure: Results From COMET. J Am Coll Cardiol 49: 963-971 [Abstract] [Full Text]  
• Goyal, A., Alexander, J. H., Hafley, G. E., Graham, S. H., Mehta, R. H., Mack, M. J., Wolf, R. K., Cohn, L. H., Kouchoukos, N. T., Harrington, R. A., Gennevois, D., Gibson, C. M., Califf, R. M., Ferguson, T. B. Jr, Peterson, E. D., PREVENT IV Investigators, (2007). Outcomes Associated With the Use of Secondary Prevention Medications After Coronary Artery Bypass Graft Surgery. Ann. Thorac. Surg. 83: 993-1001 [Abstract] [Full Text]  
• Turley, A J, Roberts, A P, Davies, A, Rowell, N, Drury, J, Smith, R H, Shyam-Sundar, A, Stewart, M J (2007). NT-proBNP and the diagnosis of left ventricular systolic dysfunction within two acute NHS trust catchment areas: the initial Teesside experience. Postgrad. Med. J. 83: 206-208 [Abstract] [Full Text]  
• Nasr, I. A., Bouzamondo, A., Hulot, J.-S., Dubourg, O., Le Heuzey, J.-Y., Lechat, P. (2007). Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. Eur Heart J 0: ehl484v1-6 [Abstract] [Full Text]  
• Thawornkaiwong, A., Pantharanontaga, J., Wattanapermpool, J. (2007). Hypersensitivity of myofilament response to Ca2+ in association with maladaptation of estrogen-deficient heart under diabetes complication. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292: R844-R851 [Abstract] [Full Text]  
• von Haehling, S., Doehner, W., Anker, S. D (2007). Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res 73: 298-309 [Abstract] [Full Text]  
• Fonarow, G. C., Abraham, W. T., Albert, N. M., Stough, W. G., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., Pieper, K., Sun, J. L., Yancy, C., Young, J. B., for the OPTIMIZE-HF Investigators and Hospitals, (2007). Association Between Performance Measures and Clinical Outcomes for Patients Hospitalized With Heart Failure. JAMA 297: 61-70 [Abstract] [Full Text]  
• Bibbins-Domingo, K., Fernandez, A. (2007). BiDil for Heart Failure in Black Patients: Implications of the U.S. Food and Drug Administration Approval. ANN INTERN MED 146: 52-56 [Abstract] [Full Text]  
• Authors/Task Force Members, , Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., Malmberg, K., Priori, S., Ostergren, J., Tuomilehto, J., Thrainsdottir, I., Other Contributors, , Vanhorebeek, I., Stramba-Badiale, M., Lindgren, P., Qiao, Q., ESC Committee for Practice Guidelines (CPG), , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, J., Dean, V., Deckers, J., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J., Zamorano, J. L., Document Reviewers, , Deckers, J. W., Bertrand, M., Charbonnel, B., Erdmann, E., Ferrannini, E., Flyvbjerg, A., Gohlke, H., Juanatey, J. R. G., Graham, I., Monteiro, P. F., Parhofer, K., Pyorala, K., Raz, I., Schernthaner, G., Volpe, M., Wood, D. (2007). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28: 88-136 [Full Text]  
• Morley, D., Litwak, K., Ferber, P., Spence, P., Dowling, R., Meyns, B., Griffith, B., Burkhoff, D. (2007). Hemodynamic effects of partial ventricular support in chronic heart failure: Results of simulation validated with in vivo data. J. Thorac. Cardiovasc. Surg. 133: 21-28 [Abstract] [Full Text]  
• Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W. (2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation 114: 2871-2891 [Full Text]  
• Daubeney, P. E. F., Nugent, A. W., Chondros, P., Carlin, J. B., Colan, S. D., Cheung, M., Davis, A. M., Chow, C.W., Weintraub, R. G., on behalf of the National Australian Childhood Car, (2006). Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study. Circulation 114: 2671-2678 [Abstract] [Full Text]  
• Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Inanc, T., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A. (2006). Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy. J Am Coll Cardiol 48: 2258-2262 [Abstract] [Full Text]  
• Skali, H., Pfeffer, M. A., Lubsen, J., Solomon, S. D. (2006). Variable Impact of Combining Fatal and Nonfatal End Points in Heart Failure Trials. Circulation 114: 2298-2303 [Abstract] [Full Text]  
• Kim, J., Ogai, A., Nakatani, S., Hashimura, K., Kanzaki, H., Komamura, K., Asakura, M., Asanuma, H., Kitamura, S., Tomoike, H., Kitakaze, M. (2006). Impact of Blockade of Histamine H2 Receptors on Chronic Heart Failure Revealed by Retrospective and Prospective Randomized Studies. J Am Coll Cardiol 48: 1378-1384 [Abstract] [Full Text]  
• Cook, S., Togni, M., Schaub, M. C., Wenaweser, P., Hess, O. M. (2006). High heart rate: a cardiovascular risk factor?. Eur Heart J 27: 2387-2393 [Full Text]  
• Suma, H., Isomura, T., Horii, T., Nomura, F. (2006). Septal anterior ventricular exclusion procedure for idiopathic dilated cardiomyopathy.. Ann. Thorac. Surg. 82: 1344-1348 [Abstract] [Full Text]  
• Gheorghiade, M., Sopko, G., De Luca, L., Velazquez, E. J., Parker, J. D., Binkley, P. F., Sadowski, Z., Golba, K. S., Prior, D. L., Rouleau, J. L., Bonow, R. O. (2006). Navigating the Crossroads of Coronary Artery Disease and Heart Failure. Circulation 114: 1202-1213 [Full Text]  
• Developed in Collaboration With the European Heart, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48: e247-e346 [Full Text]  
• Ramsey, S. D., Hobbs, F. D. R. (2006). Chronic Obstructive Pulmonary Disease, Risk Factors, and Outcome Trials: Comparisons with Cardiovascular Disease. Proc Am Thorac Soc 3: 635-640 [Abstract] [Full Text]  
• Writing Committee Members, , Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 651-745 [Full Text]  
• Writing Committee Members, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 746-837 [Full Text]  
• Groban, L., Butterworth, J. (2006). Perioperative management of chronic heart failure.. Anesth. Analg. 103: 557-575 [Abstract] [Full Text]  
• Howard, P. A, Cheng, J. W., Crouch, M. A, Colucci, V. J, Kalus, J. S, Spinler, S. A, Munger, M. (2006). Drug Therapy Recommendations from the 2005 ACC/AHA Guidelines for Treatment of Chronic Heart Failure. The Annals of Pharmacotherapy 40: 1607-1616 [Abstract] [Full Text]  
• Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S. (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society . J Am Coll Cardiol 48: e149-e246 [Full Text]  
• Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA TASK FORCE MEMBERS, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC COMMITTEE FOR PRACTICE GUIDELINES, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114: e257-e354 [Full Text]  
• Smith, N. J., Luttrell, L. M. (2006). Signal Switching, Crosstalk, and Arrestin Scaffolds: Novel G Protein-Coupled Receptor Signaling in Cardiovascular Disease. Hypertension 48: 173-179 [Full Text]  
• Liggett, S. B., Mialet-Perez, J., Thaneemit-Chen, S., Weber, S. A., Greene, S. M., Hodne, D., Nelson, B., Morrison, J., Domanski, M. J., Wagoner, L. E., Abraham, W. T., Anderson, J. L., Carlquist, J. F., Krause-Steinrauf, H. J., Lazzeroni, L. C., Port, J. D., Lavori, P. W., Bristow, M. R. (2006). A polymorphism within a conserved beta1-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc. Natl. Acad. Sci. USA 103: 11288-11293 [Abstract] [Full Text]  
• Butler, J., Young, J. B., Abraham, W. T., Bourge, R. C., Adams, K. F. Jr, Clare, R., O'Connor, C., for the ESCAPE Investigators, (2006). Beta-Blocker Use and Outcomes Among Hospitalized Heart Failure Patients. J Am Coll Cardiol 47: 2462-2469 [Abstract] [Full Text]  
• Willenheimer, R., Lechat, P. (2006). New concepts in managing patients with chronic heart failure: the evolving importance of beta-blockade. Eur Heart J Suppl 8: C3-C4 [Full Text]  
• Lechat, P. (2006). The evolution of heart failure management over recent decades: from CONSENSUS to CIBIS. Eur Heart J Suppl 8: C5-C12 [Abstract] [Full Text]  
• Silke, B. (2006). Beta-blockade in CHF: pathophysiological considerations. Eur Heart J Suppl 8: C13-C18 [Abstract] [Full Text]  
• Funck-Brentano, C. (2006). Beta-blockade in CHF: from contraindication to indication. Eur Heart J Suppl 8: C19-C27 [Abstract] [Full Text]  
• Follath, F. (2006). Beta-blockade today: the gap between evidence and practice. Eur Heart J Suppl 8: C28-C34 [Abstract] [Full Text]  
• Ponikowski, P. (2006). Rationale and design of CIBIS III. Eur Heart J Suppl 8: C35-C42 [Abstract] [Full Text]  
• Willenheimer, R. (2006). How to begin treatment in chronic heart failure? Results of CIBIS III. Eur Heart J Suppl 8: C43-C50 [Abstract] [Full Text]  
• Lechat, P., Willenheimer, R. (2006). Discussion summary: key clinical questions. Eur Heart J Suppl 8: C58-C60 [Full Text]  
• Gheorghiade, M., van Veldhuisen, D. J., Colucci, W. S. (2006). Contemporary Use of Digoxin in the Management of Cardiovascular Disorders. Circulation 113: 2556-2564 [Full Text]  
• Nikolaidis, L. A., Poornima, I., Parikh, P., Magovern, M., Shen, Y.-T., Shannon, R. P. (2006). The Effects of Combined Versus Selective Adrenergic Blockade on Left Ventricular and Systemic Hemodynamics, Myocardial Substrate Preference, and Regional Perfusion in Conscious Dogs With Dilated Cardiomyopathy. J Am Coll Cardiol 47: 1871-1881 [Abstract] [Full Text]  
• Cesario, D. A., Dec, G. W. (2006). Implantable Cardioverter- Defibrillator Therapy in Clinical Practice. J Am Coll Cardiol 47: 1507-1517 [Abstract] [Full Text]  
• Gardner, R. S., McDonagh, T. A., MacDonald, M., Dargie, H. J., Murday, A. J., Petrie, M. C. (2006). Who needs a heart transplant?. Eur Heart J 27: 770-772 [Full Text]  
• (2006). Additional Information. JAMA 295: E1-E6 [Full Text]  
• Rocca, H. P. B.-L., Capraro, J., Kiowski, W. (2006). Compliance by Referring Physicians With Recommendations on Heart Failure Therapy from a Tertiary Center. J CARDIOVASC PHARMACOL THER 11: 85-92 [Abstract]  
• Bredin, F., Franco-Cereceda, A. (2006). Reversed remodelling in dilated cardiomyopathy by passive containment surgery is associated with decreased circulating levels of endothelin-1. Eur. J. Cardiothorac. Surg. 29: 299-303 [Abstract] [Full Text]  
• Ghio, S., Magrini, G., Serio, A., Klersy, C., Fucilli, A., Ronaszeki, A., Karpati, P., Mordenti, G., Capriati, A., Poole-Wilson, P. A., Tavazzi, L., on behalf of the SENIORS investigators, (2006). Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy. Eur Heart J 27: 562-568 [Abstract] [Full Text]  
• Shelton, R J, Rigby, A S, Cleland, J G F, Clark, A L (2006). Effect of a community heart failure clinic on uptake of {beta} blockers by patients with obstructive airways disease and heart failure. Heart 92: 331-336 [Abstract] [Full Text]  
• Gillespie, N. D (2006). The diagnosis and management of chronic heart failure in the older patient. Br Med Bull 75-76: 49-62 [Abstract] [Full Text]  
• Melzer, C., Witte, J., Reibis, R., Bondke, H.J., Combs, W., Stangl, K., Baumann, G., Theres, H. (2006). Predictors of chronotropic incompetence in the pacemaker patient population.. Europace 8: 70-75 [Abstract] [Full Text]  
• Aranda, J. M. Jr, Woo, G. W., Schofield, R. S., Handberg, E. M., Hill, J. A., Curtis, A. B., Sears, S. F., Goff, J. S., Pauly, D. F., Conti, J. B. (2005). Management of Heart Failure After Cardiac Resynchronization Therapy: Integrating Advanced Heart Failure Treatment With Optimal Device Function. J Am Coll Cardiol 46: 2193-2198 [Abstract] [Full Text]